Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merrell Dow pricing

Executive Summary

In recent speech to the Ohio State College of Pharmacy, Merrell Dow VP-Public Affairs Robert Ingram said the company is "in effect, moving toward a true one price policy," by reducing differential between contract customers, and whslrs. and retailers. He explained that the new policy "should result in minimizing the possibility of diversion." Ingram added: "We are realizing that, regardless of what the customer is called (hospital, retailer, HMO) they are in fact competing for the same patients. We should allow them to compete equitably"

Latest Headlines
See All
UsernamePublicRestriction

Register

PS008556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel